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Abstract
We firstly report a postoperative hemodialysis patient who was co-administered with amiodarone and dexmedetomidine
and developed severe bradycardia followed by cardiac arrest. A 79-year-old male patient underwent an amputation of
the right lower extremity. The electrocardiogram of the patient showed a complete right bundle branch block with left
anterior fascicular block before the anesthesia, and paroxysmal atrial tachycardia over 200 beats/min lasting 15 min was
observed during surgery. After admission to the intensive care unit, the intensivist and the consultant cardiologist decided
to treat tachycardia using amiodarone. The initial dosing of amiodarone and the maintenance infusion succeeded to
decrease the heart rate. Approximately 2 h and a half after the start of dexmedetomidine infusion for sedation, the heart
rate gradually declined and severe bradycardia suddenly followed by cardiac arrest was observed. Resuscitation was
promptly initiated and the patient regained sinus rhythm without delay. In retrospective analysis, the monitoring record
of the electrocardiogram revealed the marked atrioventricular conduction abnormalities. This is the first case report
concerning a cardiac arrest induced by amiodarone and dexmedetomidine.
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Background
Dexmedetomidine is one of well-known sedatives, and
administration of dexmedetomidine has become a popu-
lar regimen in intensive care unit [1–3]. Dexmedetomi-
dine has been considered as a preferable drug among
intensivists because of it showing less respiratory and
cardiovascular depression [4]. Recently, the application
of dexmedetomidine in clinical settings is expanding in
Japan and in western countries [1]. However, we previ-
ously reported that dexmedetomidine showed a fatal
cardiovascular complication including cardiac arrest and
reviewed the literature [5]. Now, we firstly present an-
other patient who developed severe bradycardia followed
by cardiac arrest induced by the co-administration of
amiodarone and dexmedetomidine.
Case presentation
A 79-year-old male patient was transferred to our hospital
for a scheduled amputation surgery of the right lower
extremity. He had suffered diabetes and subsequent
chronic renal insufficiency. The hemodialysis was intro-
duced 9 years ago in other hospital. The chronic heart
failure was pointed out, and the echocardiography demon-
strated that the ejection fraction of the left ventricle was
only 14 % at the preoperative visit. The history of coronary
artery diseases was strongly suspected; however, the de-
tailed information could not be obtained. His electrocar-
diogram showed sinus rhythm and a sign of complete
right bundle branch block with left anterior fascicular
block (Fig. 1) [6]. The heart rate was about 130 beats/min,
and the QTc interval was 482 ms. The hemodialysis had
continued three times a week, and other laboratory data
was within normal limits. The patient had been admitted
to another hospital, and the sign of arteriosclerosis obliter-
ans was worsening with ischemic change. He was trans-
ferred to our hospital for the operation.
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The use of local anesthetics on the popliteal sciatic
nerve block was planned. Using an ultrasound device,
the nerve was identified, and the sufficient amount of
analgesia was confirmed after the injection of 20 ml of
0.75 % ropivacaine and 20 ml of 2 % mepivacaine with-
out any complications including paresthesia. Immedi-
ately after the beginning of surgery, the anesthesiologist
administered propofol at a rate of 2 mg/kg/h; however,
the blood pressure of the patient (94/60 mmHg) lowered
to 62/42 mmHg, and the infusion was discontinued.
During the anesthesia, sudden paroxysmal atrial tachy-
cardia over 200 beats/min was observed. The tachycar-
dia lasted approximately 15 min. The anesthesiologist
started to prepare to administer an antiarrhythmic agent
(detail was unknown), but the heart rate decreased be-
fore the intervention.
The patient was admitted to the intensive care unit after
the anesthesia for observation. Approximately 2 h later,
the heart rate of patient increased to 130–140 beats/min
with atrial fibrillation. The intensivist and the consultant
cardiologist decided to treat tachycardia with atrial fibrilla-
tion using amiodarone. The initial dosing of amiodarone
(125 mg/30 min) was followed by fast maintenance dosing
(50 mg/h). The heart rate decreased to approximately
100/min during the 2 h after the start of infusion. The
infusion rate of amiodarone was reduced to 25 mg/h.
After 5 h from the admission to the intensive care unit, in-
fusion of dexmedetomidine was initiated for sedation at a
rate of 0.3 μg/kg/h. The heart rate of the patient gradually
decreased to 90 beats/min (Fig. 2, upper row). The QTc
interval was prolonged to 526 ms. The monitoring elec-
trocardiogram showed sinus rhythm with atrioventricular
block.
The dexmedetomidine infusion was continued for 2 h
and a half. Then, the heart rate suddenly decreased to
40 beats/min. The complete atrioventricular block
along with ectopic rhythm was followed by sinus arrest
without escaped beat was occurred (Fig. 2, lower row).
Cardiopulmonary resuscitation was promptly initiated.
One milligram of epinephrine was administered three
times during chest compression and emergency orotra-
cheal intubation. Recovery of spontaneous circulation
was observed within 8 min, and the patient regained
sinus rhythm and appropriate blood pressure. Mechan-
ical ventilation was started, and spontaneous respir-
ation was observed. Continuous hemodiafiltration was
Fig. 1 The preoperative electrocardiogram of the patient at admission to the hospital. Complete right bundle branch block with left anterior
fascicular block was observed
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applied for correcting volume abnormalities caused by
resuscitation. Immediately after the resuscitation, blood
gas analysis showed acidemia (pH 7.05) and hyperlacta-
temia (13.3 mmol/l); however, both abnormalities dis-
appeared quickly. The infusion of dexmedetomidine
was aborted.
Next morning, the patient’s trachea was extubated with-
out any neurological complications. At post-operative day
3, slight liver dysfunction was revealed by laboratory ex-
aminations; however, the general condition was improved.
The patient was moved to the general ward at post-
operative day 6 and discharged to the former hospital at
day 10 in good course.
This is the first case report describing a patient pre-
senting cardiac arrest induced by amiodarone and dex-
medetomidine. Both drugs are considered as negative
chronotropic agents and would suppress the cardiac
conduction system. The additive or synergistic inter-
action on the impulse conduction was strongly
suspected for the etiology of cardiac arrest. The pre-
operative electrocardiogram of the patient showed con-
duction abnormality, e.g., complete right bundle branch
block with left anterior fascicle block, and the conduc-
tion dysfunction might be a risk factor for administra-
tion of the drugs [5]. We should pay more attention to
the possibility of bradycardia; however, the heart rate of
the patient showed a consistent tendency of tachycardia
before the event.
Amiodarone is one of the most popular antiarrhythmic
drugs and widely used [7]. The applicable arrhythmia of
amiodarone includes ventricular arrhythmia, e.g., ventricu-
lar premature beat, ventricular tachycardia, and supraven-
tricular arrhythmia, e.g., tachycardia with atrial fibrillation.
Although amiodarone showed a wide spectrum of antiar-
rhythmic effect, a variety of complications has been
reported on the organs, including the heart, thyroid, liver,
eyes, and lungs [8, 9]. The most common complication is
bradycardia or conduction disturbance and sympathetic β
blocking effect [10]. Kim et al. [10] reviewed that
amiodarone-induced bradycardia and atrioventricular block
were common adverse effects of amiodarone owing to the
calcium channel blocking activity. Amiodarone also signifi-
cantly prolongs ventricular repolarization, i.e., QTc interval
[11], and the effect was consistent with the change in the
electrocardiogram of the current patient.
A fatal arrhythmia, ventricular tachycardia, is one of
the most recommended conditions to administer amio-
darone. We could not find any report describing that
amiodarone itself induces cardiac arrest. Tsimogianni
et al. [12] reported that administration of itraconazole
provoked cardiac arrest in a patient administered with
amiodarone. The patient received amiodarone for a
Fig. 2 Upper: The monitoring record of the electrocardiogram after the administration of amiodarone. Progressive atrioventricular block was
observed. Lower: The record of the electrocardiogram immediately before the sinus arrest. The complete atrioventricular block with ectopic beat
was observed
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treatment of ischemic stroke associated with atrial fib-
rillation. The administration of itraconazole induced
hypotension and subsequent cardiac arrest. The same
episode was observed 2 months later, and the antifungal
treatment was changed to caspofungin.
Dexmedetomidine decreases heart rate. An incidence
of severe bradycardia might be rare [13, 14]; however,
we suspect that some of the cases with atrioventricular
block induced by the administration of dexmedetomi-
dine were overlooked [5, 15]. Moderate bradycardia with
atrioventricular block would be misdiagnosed as a slow
sinus rhythm in bipolar electrocardiography monitoring
[16]. Usually, intensivists might pay attention to the
value of the heart rate, not the pattern of the electrocar-
diogram. Dexmedetomidine reduces heart rate without a
prolongation of the QT interval; thus, QTc interval is
shortened [17, 18]. Although the apparent antiarrhyth-
mic effect of dexmedetomidine in human is not known,
a possibility of preventing the effect against ventricular
tachycardia was demonstrated in animal experiment
[19]. Recently, Narisawa et al. [20] demonstrated that
dexmedetomidine sedation reduced the incidence of
postoperative atrial fibrillation in cardiovascular surgery
patients.
Conclusion
Administration of dexmedetomidine to a patient receiving
negative chronotropic drugs should be re-considered, and
further attention and intensive monitoring are absolutely
required.
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